MAI Capital Management’s Pliant Therapeutics PLRX Stock Holding History

MAI Capital Management’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-400	Closed	-$504	–	4008
2026 Q1	$504	Hold	400	–	–	﹤0.01%	4415
2025 Q4	$488	Hold	400	–	–	﹤0.01%	3831
2025 Q3	$592	Hold	400	–	–	﹤0.01%	3592
2025 Q2	$464	Hold	400	–	–	﹤0.01%	3776
2025 Q1	$540	Hold	400	–	–	﹤0.01%	3226
2024 Q4	$5.27K	Buy	+400	New	+$5.46K	﹤0.01%	2754

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

MAI Capital Management's PLRX Position: Q2 2026 in Review

MAI Capital Management sold out of Pliant Therapeutics (PLRX) in Q2 2026, closing a stake of 400 shares — an estimated $504 sold.

MAI Capital Management first reported a position in PLRX in Q4 2024 and held it in 6 quarters. The position peaked at $5.27K in Q4 2024. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

MAI Capital Management reported no remaining Pliant Therapeutics position as of Q2 2026 after selling out during the quarter.
MAI Capital Management sold 400 Pliant Therapeutics shares in Q2 2026, an estimated $504.
MAI Capital Management first reported a position in Pliant Therapeutics in Q4 2024 and held it in 6 quarters.
MAI Capital Management's Pliant Therapeutics position peaked at $5.27K in Q4 2024.
86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.